Nichepharm Lifesciences (P) Ltd. is a pharmaceutical company targeting the thriving market for sterile injectable and biologics in the US and Europe, while also aiming to provide affordable medicines for the Indian subcontinent and ROW markets. The company, established in 2019, specializes in manufacturing niche and challenging pharmaceutical dosages, benefitting from the extensive expertise of its promoters with over 2 decades of experience in managing sterile facilities.
The company is a joint venture between Sobti Family and Recipharm AB, one of the top 5 CDMOs globally. This strategic partnership provides brand recognition, market intelligence, access to cutting-edge technology, and entry to markets with substantial barriers. Nichepharm's headquarters is in Gurgaon, Haryana, with a state-of-the-art manufacturing facility commissioned in 2021 at Selaqui Dehradun, compliant with international regulatory authorities and capable of manufacturing a wide range of small volume parenteral, offering the largest capacities in the injectable space in India under one roof.
With the slogan "Aiming For The Next Level," Nichepharm's relentless pursuit of excellence is evident in its product and service offerings, tailored to achieve the highest levels of customer satisfaction. This ambitious approach and its strategic partnerships position Nichepharm Lifesciences as a noteworthy player in the pharmaceutical industry, poised for significant growth and impact.
There is no investment information
No recent news or press coverage available for Nichepharm Lifesciences (P) Ltd..